Yushi Matsuo Selected Research

JTE-952

1/2020	Pharmacological Properties of JTE-952, an Orally Available and Selective Colony Stimulating Factor 1 Receptor Kinase Inhibitor.
1/2020	JTE-952 Suppresses Bone Destruction in Collagen-Induced Arthritis in Mice by Inhibiting Colony Stimulating Factor 1 Receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yushi Matsuo Research Topics

Disease

2	Experimental Arthritis 01/2020 - 01/2020
2	Arthritis (Polyarthritis) 01/2020 - 01/2020
2	Osteoporosis 10/2011 - 03/2011
1	Rheumatoid Arthritis 01/2020
1	Inflammation (Inflammations) 01/2020

Drug/Important Bio-Agent (IBA)

2	JTE-952IBA 01/2020 - 01/2020
2	Calcium-Sensing ReceptorsIBA 10/2011 - 03/2011
1	LigandsIBA 01/2020
1	Tartrate-Resistant Acid PhosphataseIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Macrophage Colony-Stimulating FactorIBA 01/2020
1	Anabolic AgentsIBA 10/2011
1	JTT 305IBA 10/2011
1	Pharmaceutical PreparationsIBA 03/2011
1	Parathyroid Hormone (Parathormone)IBA 03/2011

Therapy/Procedure

1	Therapeutics 01/2020
1	Injections 03/2011